Quantum-S a News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

21.11.24	Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event (Businesswire)
20.11.24	Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology (Businesswire)
20.11.24	Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA (Businesswire)
20.11.24	Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform (Businesswire)
20.11.24	Quantum-Si and Planet Innovation to Partner on Proteus™ (Businesswire)
18.11.24	Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
13.11.24	Quantum-Si Honored with Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™ (Businesswire)
12.11.24	Quantum-Si Reports Third Quarter 2024 Financial Results (Businesswire)
07.11.24	University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Si’s Next-Gen Protein Sequencer™ Platinum® (Businesswire)
05.11.24	Quantum-Si to Participate in Upcoming Investment Conferences (Businesswire)
31.10.24	Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024 (Businesswire)
30.10.24	Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting (Businesswire)
23.10.24	Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 (Businesswire)
17.10.24	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
10.10.24	Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024 (Businesswire)
24.09.24	Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing (Businesswire)
19.09.24	Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024 (Businesswire)
04.09.24	Liberate Bio Integrates Quantum-Si’s Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development (Businesswire)
27.08.24	Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider (Businesswire)
07.08.24	Quantum-Si Reports Second Quarter 2024 Financial Results (Businesswire)
30.07.24	Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference (Businesswire)
17.07.24	Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024 (Businesswire)
04.10.22	Quantum-Si Appoints Jeff Hawkins As Chief Executive Officer (RTTNews)
29.07.22	Quantum-Si to Participate at Two Upcoming Investor Conferences (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V